Researcher in CRISPR gene therapy group

We announce 80%, one-year extendable researcher position in the CRISPR gene therapy group led by Emma Haapaniemi to be based at NCMBM, University of Oslo & Oslo University Hospital. We welcome applications both from recent PhD graduates and more experienced scientists.

The successful candidate will join a highly integrated and motivated team with diverse skills and expertise across molecular biology and immunology. The work tasks will concentrate on optimizing and scaling up protocols for efficient mutation correction in human T cells and hematopoietic stem cells utilizing CRISPR-Cas9 gene editing technologies. Examples of work tasks include optimization of patient-derived T cell and stem cell ex vivo editing & culturing conditions; establishing functional assays; design and optimizing high-throughput biology experiments in robotics platforms; setting up custom Next Generation Sequencing libraries and technologies; and scale up protocols to pre-GMP and GMP scale.